British drug major AstraZeneca Plc announced its agreement with the US Government to supply up to 500,000 additional doses of potential COVID-19 antibody treatment AZD7442. Following the announcement, AstraZeneca shares were gaining around 3 percent in the morning trade in London, and more than 1 pe